WINTON GROUP Ltd Boosts Stock Position in CorVel Co. (NASDAQ:CRVL)

WINTON GROUP Ltd boosted its holdings in shares of CorVel Co. (NASDAQ:CRVL) by 757.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 32,628 shares of the business services provider’s stock after purchasing an additional 28,824 shares during the quarter. WINTON GROUP Ltd’s holdings in CorVel were worth $3,630,000 as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of the business. Advisors Asset Management Inc. increased its position in shares of CorVel by 121.7% during the 3rd quarter. Advisors Asset Management Inc. now owns 204 shares of the business services provider’s stock valued at $67,000 after purchasing an additional 112 shares during the last quarter. Point72 DIFC Ltd purchased a new stake in shares of CorVel in the third quarter valued at $88,000. Fifth Third Bancorp lifted its holdings in shares of CorVel by 45.9% in the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after acquiring an additional 101 shares during the last quarter. Jones Financial Companies Lllp purchased a new position in shares of CorVel during the 4th quarter worth about $37,000. Finally, US Bancorp DE grew its holdings in CorVel by 225.4% during the 4th quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 266 shares during the last quarter. Institutional investors own 51.36% of the company’s stock.

Insiders Place Their Bets

In related news, Director Steven J. Hamerslag sold 10,000 shares of CorVel stock in a transaction dated Thursday, February 6th. The stock was sold at an average price of $123.48, for a total value of $1,234,800.00. Following the completion of the sale, the director now directly owns 314,000 shares in the company, valued at $38,772,720. The trade was a 3.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Alan Hoops sold 10,200 shares of the company’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the sale, the director now directly owns 118,213 shares of the company’s stock, valued at approximately $13,758,811.07. This trade represents a 7.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 32,200 shares of company stock worth $3,824,115 in the last three months. Corporate insiders own 47.57% of the company’s stock.

CorVel Stock Up 0.4 %

CRVL opened at $111.95 on Friday. The business has a fifty day moving average of $112.20 and a 200 day moving average of $114.34. The stock has a market cap of $5.75 billion, a P/E ratio of 65.85 and a beta of 1.06. CorVel Co. has a 52-week low of $76.20 and a 52-week high of $128.61.

CorVel (NASDAQ:CRVL) last issued its earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of CorVel from a “buy” rating to a “hold” rating in a research note on Thursday, March 13th.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.